Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11695842rdf:typepubmed:Citationlld:pubmed
pubmed-article:11695842lifeskim:mentionsumls-concept:C0021359lld:lifeskim
pubmed-article:11695842lifeskim:mentionsumls-concept:C0025266lld:lifeskim
pubmed-article:11695842lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:11695842lifeskim:mentionsumls-concept:C0021463lld:lifeskim
pubmed-article:11695842lifeskim:mentionsumls-concept:C0033382lld:lifeskim
pubmed-article:11695842pubmed:issue3lld:pubmed
pubmed-article:11695842pubmed:dateCreated2001-11-6lld:pubmed
pubmed-article:11695842pubmed:abstractTextSpecific assays have been developed for bioactive inhibin dimers, inhibin A and B, and inhibin alpha-subunit precursor pro alphaC. To better understand the role of serum inhibin pro alphaC in infertile men, the authors measured these forms of inhibin in sera from 39 infertile men and analyzed inhibin relationships with serum gonadotropins, testosterone, and estradiol. All subjects had oligozoospermia. Inhibin A levels were undetectable in all subjects. Inhibin B concentrations were 117 +/- 59 pg/mL. Inhibit B concentrations correlated negatively with serum FSH (r = .584, p < .0001) and positively with sperm count (p < .01) and bilateral testicular volume (r = .607, p < .0001). The concentration of pro alphaC was 556 +/- 236 pg/mL (normal range, 446 +/- 28). Inhibin pro alphaC showed no correlation with serum FSH, LH, testosterone, sperm concentration, and bilateral testicular volume. In addition, inhibin pro alphaC was not correlated with inhibin B. Pro alphaC is unlikely to be a useful marker for spermatogenesis in infertile men compared with inhibin B.lld:pubmed
pubmed-article:11695842pubmed:languageenglld:pubmed
pubmed-article:11695842pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11695842pubmed:citationSubsetIMlld:pubmed
pubmed-article:11695842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11695842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11695842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11695842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11695842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11695842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11695842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11695842pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11695842pubmed:statusMEDLINElld:pubmed
pubmed-article:11695842pubmed:issn0148-5016lld:pubmed
pubmed-article:11695842pubmed:authorpubmed-author:YamazakiIIlld:pubmed
pubmed-article:11695842pubmed:authorpubmed-author:OkadaHHlld:pubmed
pubmed-article:11695842pubmed:authorpubmed-author:KamidonoSSlld:pubmed
pubmed-article:11695842pubmed:authorpubmed-author:FujisawaMMlld:pubmed
pubmed-article:11695842pubmed:authorpubmed-author:DobashiMMlld:pubmed
pubmed-article:11695842pubmed:issnTypePrintlld:pubmed
pubmed-article:11695842pubmed:volume47lld:pubmed
pubmed-article:11695842pubmed:ownerNLMlld:pubmed
pubmed-article:11695842pubmed:authorsCompleteYlld:pubmed
pubmed-article:11695842pubmed:pagination191-4lld:pubmed
pubmed-article:11695842pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:meshHeadingpubmed-meshheading:11695842...lld:pubmed
pubmed-article:11695842pubmed:articleTitleSerum inhibin pro alphaC in infertile men.lld:pubmed
pubmed-article:11695842pubmed:affiliationDepartment of Urology, Kobe University School of Medicine, Japan. masato@med.Kobe-u.ac.jplld:pubmed
pubmed-article:11695842pubmed:publicationTypeJournal Articlelld:pubmed